For research use only. Not for therapeutic Use.
Monlunabant(CAT: I040791) is a cannabinoid receptor type 1 (CB1) antagonist that functions by selectively blocking CB1 receptors, which are primarily found in the central nervous system and play a key role in regulating appetite, metabolism, and energy balance. As a CB1 antagonist, Monlunabant has been investigated for its potential in treating obesity, metabolic syndrome, and related disorders by suppressing appetite and promoting weight loss. It may also have applications in substance abuse and addiction research due to its influence on reward pathways. Monlunabant is a useful research compound for exploring endocannabinoid signaling and its role in metabolic and neurological regulation.
| CAS Number | 2712480-46-9 |
| Synonyms | N-[(E)-N’-[(Z)-C-[(4S)-5-(4-chlorophenyl)-4-phenyl-3,4-dihydropyrazol-2-yl]-N-[4-(trifluoromethyl)phenyl]sulfonylcarbonimidoyl]carbamimidoyl]acetamide |
| Molecular Formula | C26H22ClF3N6O3S |
| Purity | ≥95% |
| IUPAC Name | N-[(E)-N'-[(Z)-C-[(4S)-5-(4-chlorophenyl)-4-phenyl-3,4-dihydropyrazol-2-yl]-N-[4-(trifluoromethyl)phenyl]sulfonylcarbonimidoyl]carbamimidoyl]acetamide |
| InChI | InChI=1S/C26H22ClF3N6O3S/c1-16(37)32-24(31)33-25(35-40(38,39)21-13-9-19(10-14-21)26(28,29)30)36-15-22(17-5-3-2-4-6-17)23(34-36)18-7-11-20(27)12-8-18/h2-14,22H,15H2,1H3,(H3,31,32,33,35,37)/t22-/m1/s1 |
| InChIKey | GYJPQNPVIJXXTA-JOCHJYFZSA-N |
| SMILES | CC(=O)NC(=NC(=NS(=O)(=O)C1=CC=C(C=C1)C(F)(F)F)N2CC(C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4)N |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
